Aisling Capital Management’s Marker Therapeutics MRKR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $498K | Hold |
325,370
| – | – | 0.14% | 12 |
|
|
2025
Q1 | $400K | Hold |
325,370
| – | – | 0.14% | 12 |
|
|
2024
Q4 | $1.01M | Buy |
325,370
+11,084
| +4% | +$34.5K | 0.36% | 13 |
|
|
2024
Q3 | $886K | Hold |
314,286
| – | – | 0.34% | 14 |
|
|
2024
Q2 | $1.71M | Hold |
314,286
| – | – | 0.74% | 11 |
|
|
2024
Q1 | $1.35M | Hold |
314,286
| – | – | 0.46% | 12 |
|
|
2023
Q4 | $1.73M | Hold |
314,286
| – | – | 0.52% | 10 |
|
|
2023
Q3 | $1.43M | Hold |
314,286
| – | – | 0.59% | 14 |
|
|
2023
Q2 | $974K | Hold |
314,286
| – | – | 0.48% | 12 |
|
|
2023
Q1 | $223K | Hold |
314,286
| – | – | 0.11% | 16 |
|
|
2022
Q4 | $849K | Hold |
314,286
| – | – | 0.56% | 12 |
|
|
2022
Q3 | $1.16M | Hold |
314,286
| – | – | 0.77% | 13 |
|
|
2022
Q2 | $1.04M | Hold |
314,286
| – | – | 0.74% | 14 |
|
|
2022
Q1 | $1.38M | Hold |
314,286
| – | – | 0.75% | 15 |
|
|
2021
Q4 | $2.99M | Hold |
314,286
| – | – | 1.05% | 16 |
|
|
2021
Q3 | $5.31M | Hold |
314,286
| – | – | 1.06% | 16 |
|
|
2021
Q2 | $8.77M | Hold |
314,286
| – | – | 1.4% | 14 |
|
|
2021
Q1 | $7.04M | Buy |
314,286
+114,286
| +57% | +$2.56M | 1.27% | 11 |
|
|
2020
Q4 | $2.9M | Hold |
200,000
| – | – | 0.5% | 12 |
|
|
2020
Q3 | $3M | Hold |
200,000
| – | – | 0.96% | 12 |
|
|
2020
Q2 | $4.14M | Hold |
200,000
| – | – | 1.58% | 8 |
|
|
2020
Q1 | $3.8M | Hold |
200,000
| – | – | 1.66% | 9 |
|
|
2019
Q4 | $5.76M | Hold |
200,000
| – | – | 2.21% | 6 |
|
|
2019
Q3 | $10.2M | Hold |
200,000
| – | – | 5.33% | 5 |
|
|
2019
Q2 | $15.8M | Hold |
200,000
| – | – | 6.77% | 3 |
|
|
2019
Q1 | $13.2M | Hold |
200,000
| – | – | 10.06% | 5 |
|
|
2018
Q4 | $11.1M | Buy |
+200,000
| New | +$11.1M | 11.69% | 4 |
|